Tag Archives: upandcomers

‘Old guard’ generics players yield U.S. lead to Indian up-and-comers: analyst

The U.S. generics world has changed. Starting from around late 2018 to early 2019, traditional generics bigwigs Teva, Mylan, Novartis’ Sandoz, Amneal and Endo have lost out to a group of six competitors that include Indian drugmakers Aurobindo Pharma, Lupin, Dr. Reddy’s, Sun Pharma, Cipla and Canada’s Apotex in terms of weekly total prescriptions, Evercore… Read More »